A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

NCT06283966 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

5000

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Interventions

DRUG: BGF MDI 320/14.4/9.6 μg
DRUG: GFF MDI 14.4/9.6 μg

Sponsor

AstraZeneca